Eagle's Eye View: Key Points in the 2023 AFib Guideline
In this week’s View, Dr. Eagle explores stroke and bleeding risk in patients with atrial fibrillation and a CHA2DS2-VASC risk score of 1. He then discusses the important key points to remember in the recently released 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation. Finally, Dr. Eagle examines the potential value of using high-sensitivity cardiac troponin as a cardiac biomarker to predict preeclampsia.
- Kim Eagle, MD, MACC keaglemd
Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Anticoagulation Management and Atrial Fibrillation, Atrial Fibrillation/Supraventricular Arrhythmias, Heart Failure and Cardiomyopathies
Keywords: EaglesEyeView, Anticoagulants, Atrial Fibrillation, Stroke, Cardio-Obstetrics, Pre-Eclampsia, Troponin I
< Back to Listings